Allogene Therapeutics, Inc. - COM (ALLO)

Historical Portfolio Holders from Q4 2018 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
128 M
Holdings value Q1 2024
$573 M
Value change Q1 2024
+$43.9 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
149
Number of buys Q1 2024
71
Number of sells Q1 2024
-72
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
0%
CUSIP
019770106
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 128 M $573 M +$43.9 M $4.47 149
2023 Q4 120 M $384 M -$23.1 M $3.21 162
2023 Q3 128 M $406 M -$15.7 M $3.17 147
2023 Q2 131 M $650 M +$73.8 M $4.97 162
2023 Q1 115 M $566 M +$24.5 M $4.94 169
2022 Q4 111 M $696 M +$17.1 M $6.29 158
2022 Q3 102 M $1.1 B +$60.2 M $10.80 174
2022 Q2 95.1 M $1.08 B +$107 M $11.40 147
2022 Q1 91.6 M $835 M +$16.2 M $9.11 169
2021 Q4 84.4 M $1.26 B -$108 M $14.92 161
2021 Q3 86.1 M $2.21 B +$36 M $25.70 161
2021 Q2 86.3 M $2.25 B -$84.5 M $26.08 178
2021 Q1 86.5 M $3.05 B -$11.4 M $35.30 166
2020 Q4 86.8 M $2.19 B +$105 M $25.24 153
2020 Q3 82.3 M $3.1 B -$164 M $37.71 153
2020 Q2 86.2 M $3.69 B +$662 M $42.82 167
2020 Q1 73.3 M $1.43 B +$28.2 M $19.44 109
2019 Q4 71.6 M $1.86 B +$105 M $25.98 113
2019 Q3 64.6 M $1.76 B +$43.6 M $27.26 92
2019 Q2 63 M $1.69 B +$161 M $26.85 92
2019 Q1 57.7 M $1.66 B +$80.5 M $28.91 86
2018 Q4 55 M $1.47 B +$1.47 B $26.93 79